Preventive therapy for child contacts of multidrug-resistant tuberculosis: A prospective cohort study

Clinical Infectious Diseases

Volumn 57, Issue 12, 2013, Pages 1676-1684

  Seddon, James A ^a,c,d   Hesseling, Anneke C ^a   Finlayson, Heather ^b,e   Fielding, Katherine ^c   Cox, Helen ^f   Hughes, Jennifer ^f   Godfrey Faussett, Peter ^c   Schaaf, H Simon ^a,e  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e STELLENBOSCH UNIVERSITY   (South Africa)

^f MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

child; drug resistant; pediatric; preventive therapy; tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; OFLOXACIN;

ARTHRALGIA; ARTICLE; BONE PAIN; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; DIARRHEA; DRUG INDUCED HEADACHE; DRUG MEGADOSE; FEMALE; HALLUCINATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; JAUNDICE; LETHARGY; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYALGIA; NAUSEA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; TREATMENT DURATION; TUBERCULOSIS CONTROL; VISUAL DISORDER; VOMITING;

CHILD; DRUG-RESISTANT; PEDIATRIC; PREVENTIVE THERAPY; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CHILD, PRESCHOOL; ETHAMBUTOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; ISONIAZID; MALE; OFLOXACIN; PROSPECTIVE STUDIES; RISK FACTORS; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84890038932     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit655     Document Type: Article

References (46)

1. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke Jr. Childhood pulmonary tuberculosis: Old wisdom and new challenges. Am J Respir Crit Care Med 2006; 173:1078-90
2. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: A critical review of literature from the prechemotherapy era. Int J Tuberc Lung Dis 2004; 8:392-402
3. Hesseling AC, Cotton MF, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: Evidence from a South African population- based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009; 48:108-14
4. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 1970; 26:28-106
5. Gray DM, Zar H, Cotton M. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. Cochrane Database Syst Rev 2009; CD006418
6. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000; CD001363
7. World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Available at: Http://whqlibdoc.who.int/hq/2006/WHO-HTM-TB-2006.371-eng.pdf. Accessed 7 October 2013
8. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis - emergency update. Available at: Http://whqlibdoc.who.int/publications/2008/9789241547581-eng.pdf. Accessed 7 October 2013
9. Seddon JA, Godfrey-Faussett P, Hesseling AC, Gie RP, Beyers N, Schaaf HS. Management of children exposed to multidrug-resistant Mycobacterium tuberculosis. Lancet Infect Dis 2012; 12:469-79
10. Sneag DB, Schaaf HS, Cotton MF, Zar HJ. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrugresistant tuberculosis cases. Pediatr Infect Dis J 2007; 26:1142-6
11. Tochon M, Bosdure E, Salles M, et al. Management of young children in contact with an adult with drug-resistant tuberculosis, France, 2004-2008. Int J Tuberc Lung Dis 2011; 15:326-30
12. Centers for Disease Control and Prevention. Management of persons exposed to multidrug-resistant tuberculosis. MMWR Recomm Rep 1992; 41(RR-11):61-71
13. European Centre for Disease Prevention and Control. Management of contacts of MDR TB and XDR TB patients. Available at: Http://ecdc. europa.eu/en/publications/Publications/201203-Guidance-MDR-TBcontacts. pdf. Accessed 7 October 2013
14. Graham SM, Gie RP, Schaaf HS, Coulter JB, Espinal MA, Beyers N. Childhood tuberculosis: Clinical research needs. Int J Tuberc Lung Dis 2004; 8:648-57
15. Cobelens FG, Heldal E, Kimerling ME, et al. Scaling up programmatic management of drug-resistant tuberculosis: A prioritized research agenda. PLoS Med 2008; 5:e150
16. Ingham B, Brentnall D, Dale E, McFadzean J. Arthropathy induced by antibacterial fused N-alkyl-4-pyridone-3-carboxylic acids. Toxicol Lett 1977; 1:21-6
17. World Health Organization. Global tuberculosis control 2011. Available at: Http://whqlibdoc.who.int/publications/2011/9789241564380-eng.pdf. Accessed 7 October 2013
18. Schaaf HS, Gie RP, Kennedy M, Beyers N, Hesseling PB, Donald PR. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: A 30-month follow-up. Pediatrics 2002; 109:765-71
19. Ettehad D, Schaaf HS, Seddon JA, Cooke GS, Ford N. Treatment outcomes for children with multidrug-resistant tuberculosis: A systematic review and meta-analysis. Lancet Infect Dis 2012; 12:449-56
20. Coyne KM, Pozniak AL, Lamorde M, Boffito M. Pharmacology of second-line antituberculosis drugs and potential for interactions with antiretroviral agents. AIDS 2009; 23:437-46
21. Seddon JA, Hesseling AC, Marais BJ, et al. Paediatric use of second-line anti-tuberculosis agents: A review. Tuberculosis (Edinb) 2012; 92:9-17
22. Resch SC, Salomon JA, Murray M,Weinstein MC. Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med 2006; 3:e241
23. South African Health Review 2010. Health and related indicators. Available at: Http://www.hst.org.za/sites/default/files/sahr10-21.pdf. Accessed 7 October 2013
24. Seddon JA, Hesseling AC, Marais BJ, Jordaan A, Victor T, Schaaf HS. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa. Int J Tuberc Lung Dis 2012; 16:928-33
25. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr 2004; 36:1100-2
26. Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- And middle-income countries. Pediatr Infect Dis J 2008; 27:686-91
27. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: A meta-analysis. Med Care 2002; 40:794-811
28. Division of Microbiology and Infectious Diseases. Pediatric toxicity tables. November 2007 draft. Available at: Http://www.niaid.nih.gov/ LabsAndResources/resources/DMIDClinRsrch/Documents/dmidpedtox. pdf. Accessed 7 October 2013
29. Graham SM, Ahmed T, Amanullah F, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 2012; 205(suppl 2):S199-208
30. Fraser A, Paul M, Attamna A, Leibovici L. Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis. Cochrane Database Syst Rev 2006; CD005435
31. Kritski AL, Marques MJ, Rabahi MF, et al. Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis. Am J Respir Crit care Med 1996; 153:331-5
32. Bamrah S, Brostrom R, Setik L, Fred D, Kawamura M, Mase S. An ounce of prevention: Treating MDR-TB contacts in a resourcelimited setting. In: International Union of Tuberculosis and Lung Disease Conference, Berlin, Germany, 11-15 November, 2010. FA-1- 656-14:S180
33. van der Werf MJ, Sandgren A, Manissero D. Management of contacts of multidrug-resistant tuberculosis patients in the European Union and European Economic Area. Int J Tuberc Lung Dis 2012; 16:426
34. Partners in Health. The Partners in Health guide to the medical management of multidrug-resistant tuberculosis. Available at: Http:// parthealth.3cdn.net/7b69fbe8784f6c73c9-cwm6v2gyk.pdf. Accessed 7 October 2013
35. Francis J; Curry National Tuberculosis Center. Drug-resistant tuberculosis: A survival guide for clinicians. 2nd ed. Available at: Http://www. currytbcenter.ucsf.edu/drtb/docs/MDRTB-book-2011.pdf. Accessed 7 October 2013
36. Schaaf HS, Marais BJ. Management of multidrug-resistant tuberculosis in children: A survival guide for paediatricians. Paediatr Respir Rev 2011; 12:31-8
37. Al-Dabbagh M, Lapphra K, McGloin R, et al. Drug-resistant tuberculosis: Pediatric guidelines. Pediatr Infect Dis J 2011; 30:501-5
38. Feja K, McNelley E, Tran CS, Burzynski J, Saiman L. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003. Pediatr Infect Dis J 2008; 27:907-12
39. Cain KP, Nelson LJ, Cegielski JP. Global policies and practices for managing persons exposed to multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2010; 14:269-74
40. Pineiro Perez R, Mellado Pena MJ, Mendez Echevarria A, et al. Exposure to multiresisant tuberculosis: Study and follow-up of nine children [in Spanish]. An Pediatr (Barc) 2008; 68:490-5
41. Attamna A, Chemtob D, Attamna S, et al. Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: A nationwide cohort. Thorax 2009; 64:271
42. National Institute for Health and Clinical Excellence. Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Available at: Http://www.nice.org.uk/nice media/live/13422/53642/53642.pdf. Accessed 7 October 2013
43. Department of Health, Republic of South Africa. Management of drugresistant tuberculosis. Policy guidelines 2011. Available at: Http://www. doh.gov.za/docs/policy/2011/policy-TB.pdf. Accessed 7 October 2013
44. American Academy of Pediatrics. Tuberculosis. In: Pickering LK, ed. Red book: Report of the committee on infectious diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2009: 680-701
45. Passannante MR, Gallagher CT, Reichman LB. Preventive therapy for contacts of multidrug-resistant tuberculosis. A Delphi survey. Chest 1994; 106:431-4
46. van der Werf MJ, Langendam MW, Sandgren A, Manissero D. Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: Two systematic reviews. Int J Tuberc Lung Dis 2012; 16:288-96